Reference 2018-714

REF:           2018-714

Subject:       Rheumatoid Arthritis

 

Request:

  1. Within your trust how many patients do you have diagnosed with Rheumatoid Arthritis?

 

  1. How many Rheumatoid Arthritis patients have had an IFR [Individual Funding Request] put in for them to have an advanced treatment (i.e. biologic or JAK inhibitor) in the past 12 months?

 

  1. How many patients do you have diagnosed with moderate Rheumatoid Arthritis? [moderate is defined within the guidelines as patients with a DAS score of between 3.2 and 5.1]

 

  1. How many moderate Rheumatoid Arthritis patients have had an IFR [Individual Funding Request] put in for them to have an advanced treatment (i.e. biologic or JAK inhibitor) in the past 12 months?

 

  1. How many moderate Rheumatoid Arthritis patients have been granted an IFR request for an advanced treatment (i.e. biologic or JAK inhibitor) in the past 12 months?

 

  1. If possible, please state the number of patients and the name of an advanced treatment (i.e. biologic or JAK inhibitor) provided

 

 

Response:

1. Within your trust how many patients do you have diagnosed with Rheumatoid Arthritis? 91 Patients (Time period 01/12/2017 – 30/11/2018).

 

Please note the above information consists of individual patients admitted during the period stated at the top of this report with the following ICD-10 diagnosis codes in either a primary or secondary position:

 

M05.- Seropositive rheumatoid arthritis

M06.- Other rheumatoid arthritis

M08.0- Juvenile rheumatoid arthritis

M45X- Ankylosing spondylitis

2. How many Rheumatoid Arthritis patients have had an IFR [Individual Funding Request] put in for them to have an advanced treatment (i.e. biologic or JAK inhibitor) in the past 12 months? We do not hold this information, you will need to contact Bolton CCG on: https://www.boltonccg.nhs.uk/
3. How many patients do you have diagnosed with moderate Rheumatoid Arthritis? [moderate is defined within the guidelines as patients with a DAS score of between 3.2 and 5.1] We do not hold this information.
4. How many moderate Rheumatoid Arthritis patients have had an IFR [Individual Funding Request] put in for them to have an advanced treatment (i.e. biologic or JAK inhibitor) in the past 12 months? Please refer to the answer for question two.
5. How many moderate Rheumatoid Arthritis patients have been granted an IFR request for an advanced treatment (i.e. biologic or JAK inhibitor) in the past 12 months?
6. If possible, please state the number of patients and the name of an advanced treatment (i.e. biologic or JAK inhibitor) provided. We do not hold this information.

Visitor restrictions

To protect you and our staff during the current outbreak of Covid-19 we’ve put in place significant restrictions on hospital visitors.

Full details of these can be found on our website.

We would like to thank you for your understanding and helping us stop the spread of Covid-19.

Read More

Stay Home. Protect the NHS. Save Lives.

Close